This page shows the latest PsA news and features for those working in and with pharma, biotech and healthcare.
either says they don’t offer PSA tests, or you have to have a reason for it. ... The PSA test should be offered as a standard test for men over the age of 50, similar to breast cancer screening for women.
Current prostate-specific antigen (PSA) testing typically involves a blood test to detect the PSA protein made in the prostate gland, however, this test can be inaccurate. ... Around three in four men with a raised PSA level will not have cancer
Safety in this paediatric population was consistent with the known safety profile of Cosentyx for the treatment of adult and paediatric plaque psoriasis, PsA and axial spondyloarthritis, the company reported.
Benefits were also observed in other secondary endpoints, including investigator assessed rPFS, prostate specific antigen (PSA) response, time to PSA progression, and overall response rate.
moderate-to-severe plaque PsO who also had active PsA, as well as adult patients with moderate-to-severe plaque PsO or active PsA. ... Symptoms of active PsA can vary significantly, but often include joint inflammation and skin lesions.
clearance, alongside results that demonstrated positive joint efficacy, compared to existing PsA therapies. ... Through using the NMA approach to trial data, companies like Janssen are able to provide comparative evidence of PsA therapies.
More from news
Approximately 5 fully matching, plus 42 partially matching documents found.
Many men have to request the prostate cancer blood test, or PSA (Prostate Specific Antigen) test, themselves – and in some cases are even advised against doing so. ... GPs have a vital role to play by proactively engaging with men who have a higher risk
This is what BMS has secured with Bavarian Nordic's cancer vaccine targeting PSA in phase III for treatment of metastatic castration-resistant prostate cancer.
The phase II results showed a decline in PSA levels of more than 50% in the study of 124 patients.
The first peak was clearly the result of the introduction of PSA tests in the late 1980s; the cause of the second, smaller peak was not as definite, but researchers have ... attributed it to the publicity surrounding then-federal health minister Alan Rock
Future risk of prostate cancer is closely related to a man’s prostate-specific antigen (PSA) score; men screened at the age of 40 establish a baseline that can be tracked ... PSAs have always been a critical, controversial issue, which is why the
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Living with Uterine Fibroids and Endometriosis US 2022. Living with Uterine Fibroids (UF) and Endometriosis (Endo) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition,
How do you convey the risk of false positives when screening for breast cancer, or the fact that measuring PSA has no impact on surviving prostate cancer?
A few years ago, a London garage owner who owed his life to a timely PSA test, started offering free car MOT tests to men who agreed to get their prostate
Almost a third of people with psoriasis will develop PsA but patients may experience arthritic symptomsbefore any skin manifestations. ... unclear on what signs to check for a full and complete diagnosis of PsA?
More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.
No results were found
Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...